PLAINSBORO, N.J., March 20, 2019 /PRNewswire/ — Novo Nordisk today
Read moreNovo Nordisk Files for US FDA Approval of Oral Semaglutide for Blood Sugar Control and Cardiovascular Risk Reduction in Adults with Type 2 Diabetes
Opioid crisis: Only a US phenomenon?
Addiction to prescription opioids has reached a crisis level in
Read moreDenver trying again for possible 1st US drug injection site
Despite federal opposition, Denver is trying again to become what
Read moreWhy do we stay in relationships that make us unhappy?
Unfortunately, happy romantic relationships are very familiar and often the
Read moreStudy: 1 in 3 US adults eat fast food each day
A government study has found that 1 in 3 U.S.
Read moreWhat do gut decisions reveal about us?
Since the times of Ancient Greece, our behavior has been
Read moreUS drug overdose deaths surge amid fentanyl scourge
US drug overdose deaths surged to nearly 72,000 last year,
Read moreUS opioid use not declined, despite focus on abuse and awareness of risk
Use of prescription opioids in the United States has not
Read moreUS Named 'Most Dangerous' Place to Give Birth in the Developed World — Here's Where Your State Ranks
Many people think of dying during or after childbirth as
Read moreUS military develops algorithm to tell you how much caffeine you need
The coffee formula that ensures you’re full of beans: Find
Read more